Canada

Sunnyvale – October 29, 2026 -- XREAL's AURA glasses, which XREAL calls the first wired XR glasses powered by Android XR, are available to order now in the United States, Canada, Japan and South Korea. A limited-time offer sets the 12GB + 256GB model at $1,099 and the 16GB + 512GB model at $1,299. Shipping is expected to begin in mid-November.

Transparent lenses and a puck keep the weight under 95 grams

XREAL announced AURA on stage at Google's Android Developer Summit. It was developed with Google and Qualcomm Technologies and is the first wired XR glasses to launch on the Snapdragon Reality Elite Platform, according to the company.

Unlike fully enclosed headsets, AURA uses optical see-through lenses, so wearers still see the room and the people around them. The main compute and battery sit in a compact puck, which keeps the glasses under 95 grams.

United States – October 29, 2026 -- Solid Biosciences has dosed 33 children aged 1 to 10 with its investigational gene therapy SGT-003 for Duchenne muscular dystrophy, and a Phase 3 trial has enrolled its first patient.

Safety data show no liver, kidney or heart-inflammation cases

The figures come from INSPIRE DUCHENNE, a Phase 1/2, open-label, multi-center study, with data cut off on January 9, 2026. SGT-003 has been generally well tolerated using prophylactic steroids alone for immune suppression. The company reports no cases of drug-induced liver injury, thrombotic microangiopathy, atypical hemolytic uremic syndrome or myocarditis.

Cardiac monitoring has shown consistent reductions in markers of cardiac injury, with early signals of normalization. The company also reports microdystrophin expression and improvements across multiple biomarkers of muscle health.

Auburn Hills – October 29, 2026 -- Mopar is selling a limited-run '27 Dodge Charger package for $10,995 (U.S. MSRP), adding carbon-fiber parts and a cold-air intake to the two-door R/T and Scat Pack Plus. Only 270 units will be built to mark the brand's 90th anniversary in 2027.

Only 270 cars, split across three colors

Mopar will build 90 cars in each of three colors: Bludicrous, Diamond Black and White Knuckle. Of the 270 units, 243 are allocated to the U.S. and 27 to Canada. Dealer orders open in early January 2027, and production starts in spring 2027.

The car debuts at the Mopar NHRA Las Vegas Nationals at Las Vegas Motor Speedway, Oct. 30-Nov. 1. It then moves to the SEMA Show in Las Vegas, Nov. 3-6, at Mopar's new booth 59119 in the West Hall.

Boston – October 29, 2026 -- People with Parkinson's can now order WellPD, an FDA-cleared and CE-marked wrist-worn device from Empatica that tracks tremor, dyskinesia and bradykinesia at home, along with sleep and activity.

A companion app pulls those measurements into daily summaries. The aim is to help users see how their symptoms fluctuate, spot changes around medication doses and talk through those patterns with their care teams.

Symptoms shift by the hour, and memory is a poor logbook

Parkinson's symptoms can vary from one hour to the next, including as medication takes effect or wears off. In an appointment, recalling when changes happened, how long they lasted and how they affected daily life can be hard.

MIAMI – October 29, 2026 -- A new survey of 2,000 adults in the United States and Canada finds that 81% miss the sense of wonder they had as kids more than the free time they had back then. Club Med, the all-inclusive resort operator, commissioned the study from Wakefield Research as the first edition of its Art of Free Time Report 2026.

Obligations beat enjoyment for most adults

Some 87% of respondents say obligations take priority over things they want to do for enjoyment at least some of the time. For 41%, that happens most or all of the time. Club Med calls this distance between wanting more fun and making room for it the "Joy Gap."

McLean, Virginia – October 28, 2026 -- Hilton Honors members with Silver, Gold, Diamond or Diamond Reserve status can now use their Points toward hotel charges straight from their phone, with no front desk visit. The new Pay with Points benefit is live at 150 participating hotels in the U.S.

Points are applied during Digital Check Out in the app

During Digital Check Out in the Hilton Honors App, eligible members can review their folio, choose from available redemption options and apply Points toward eligible charges. Guests can do this at the hotel or on the go.

Hilton says it is the first major hotel brand to offer this through a fully digital check out. According to the company, comparable offerings require front desk assistance.

United States – October 27, 2026 -- Solid Biosciences has expanded its INSPIRE DUCHENNE gene therapy trial to 43 participants and now accepts children aged 4 to under 12, up from the previous range of 4 to under 8.

Three participants dosed with no serious adverse events

INSPIRE DUCHENNE is a first-in-human, multicenter, Phase 1/2 open-label study. It tests the safety, tolerability and efficacy of a single intravenous infusion of SGT-003, a next-generation AAV gene therapy candidate, in ambulant boys with Duchenne.

Three participants have been dosed so far. According to Solid, SGT-003 has been well tolerated to date, and no serious adverse events have been reported. The company plans to share safety, expression and biomarker data from these first three patients, along with a trial update, in the first quarter of 2025.

Global – October 27, 2026 -- Fifty-three boys with Duchenne muscular dystrophy have now received the investigational gene therapy SGT-003, and a Phase 3 trial is already enrolling patients in Australia and Canada. Solid Biosciences shared the update in a letter to the Duchenne community as the annual Parent Project Muscular Dystrophy (PPMD) conference got under way.

The Phase 1/2 trial spans ages 0 to 10

The count comes from the Phase 1/2 INSPIRE DUCHENNE trial and reflects a June 22, 2026, enrollment cutoff. Participants range from 0 to 10 years old. One of them is a 6-month-old boy who, to the company's knowledge, is the youngest child ever dosed with a microdystrophin gene therapy.

Solid reports no cases of four serious safety conditions

The company describes SGT-003 as generally well tolerated. It reports no observed cases of drug-induced liver injury, myocarditis, thrombotic microangiopathy or atypical hemolytic uremic syndrome.

United States – October 27, 2026 -- Fifteen people with Duchenne muscular dystrophy had received the investigational gene therapy SGT-003 in the INSPIRE DUCHENNE clinical study as of August 12, 2025, according to developer Solid Biosciences.

Ten trial sites span four countries

The multi-center, open-label trial now runs 10 active clinical sites in the United States, Canada, Italy, and the United Kingdom. More sites are expected to open later this year.

Solid Biosciences expects to have treated at least 20 patients aged 0 to under 12 by the end of 2025. It anticipates widening enrollment to older patients in 2026.

Canada – October 26, 2026 -- A set of Canadian banking case studies shows how mortgage insurance premiums, 0% balance transfer offers and card disputes can raise costs for ordinary customers.

Homebuyers and balance transfers face extra costs

Mr. and Ms. D put down less than 20% of the purchase price, so Canadian mortgage rules required an insured mortgage. The bank arranged the insurance. Their case centres on late disclosure of a higher premium, which added costs for the couple and ended in a low settlement.

Ms. J called her bank about a promotion offering 0% interest for 12 months on balances transferred from other cards. The bank confirmed the offer and a 3% transfer fee. Missed payments later increased her interest costs.

Ms. W always paid her cashback card in full. The 0% offer would have saved her money compared with the usual 20.99% on balances and 21.99% on cash advances. She later challenged the interest charges she received.